119 related articles for article (PubMed ID: 2049109)
1. Cytosolic ionized calcium in human platelets: the influence of collagen and a novel antiplatelet agent.
Gollamudi R; Dillingham EO; Bond SE; Lyman BA
Biochem Biophys Res Commun; 1991 Jun; 177(2):888-93. PubMed ID: 2049109
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activities of the novel antiplatelet agent alpha,alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide.
Lyman BA; Bond SE; Dillingham EO; Lawrence WH; Gollamudi R
Res Commun Chem Pathol Pharmacol; 1992 Dec; 78(3):279-88. PubMed ID: 1475529
[TBL] [Abstract][Full Text] [Related]
3. Effect of 764-3 on aggregation and calcium movements in aequorin-loaded human platelets.
Wu H; Li J; Peng L; Teng B; Zhai Z
Chin Med Sci J; 1996 Mar; 11(1):49-52. PubMed ID: 9206120
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.
Gollamudi R; Dillingham EO; Bond SE
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):375-83. PubMed ID: 8075309
[TBL] [Abstract][Full Text] [Related]
5. The effect of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene on human blood platelet structural physiology.
Lasslo A; White JG
Biochim Biophys Acta; 1984 Oct; 777(1):37-40. PubMed ID: 6435673
[TBL] [Abstract][Full Text] [Related]
6. Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.
Handa RK; Dillingham EO; Gollamudi R
Life Sci; 1995; 57(10):983-8. PubMed ID: 7643723
[TBL] [Abstract][Full Text] [Related]
7. Measurement of thromboxane A2-induced elevation of ionized calcium in collagen-stimulated platelets with the photoprotein, aequorin.
Nakano T; Terawaki A; Arita H
J Biochem; 1986 Apr; 99(4):1285-8. PubMed ID: 3711064
[TBL] [Abstract][Full Text] [Related]
8. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet effects of R,S-(meso)-alpha, alpha'-bis[3-(N,N-diethylcarbamoyl) piperidino]-p-xylene ex vivo in the dog and in vivo in the mouse.
Han G; Bannerman D; Handa RK; Dillingham EO; Lawrence WH; Gollamudi R
Gen Pharmacol; 1997 Apr; 28(4):617-21. PubMed ID: 9147034
[TBL] [Abstract][Full Text] [Related]
10. Effect of common agonists on cytoplasmic ionized calcium concentration in platelets. Measurement with 2-methyl-6-methoxy 8-nitroquinoline (quin2) and aequorin.
Ware JA; Johnson PC; Smith M; Salzman EW
J Clin Invest; 1986 Mar; 77(3):878-86. PubMed ID: 3081576
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PAF-induced human platelet aggregation by antithrombotic nipecotomides.
Herron D; Dillingham EO; Lyman BA; Zheng X; Bond SE; Salgia SR; Gollamudi R
Prostaglandins Leukot Essent Fatty Acids; 1995 May; 52(5):309-18. PubMed ID: 7630919
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombus formation in vivo by novel antiplatelet agent.
Marzec UM; Kelly AB; Hanson SR; Lasslo A; Harker LA
Arteriosclerosis; 1990; 10(3):367-71. PubMed ID: 2140503
[TBL] [Abstract][Full Text] [Related]
13. Enantioselective antiplatelet actions of nipecotamides.
Gollamudi R; Feng Z; Dillingham EO; Bond SE; Han G; Salgia S
Thromb Res; 1993 Feb; 69(4):361-7. PubMed ID: 8470057
[TBL] [Abstract][Full Text] [Related]
14. Ca2+ influx mediated through the GPIIb/IIIa complex during platelet activation.
Yamaguchi A; Yamamoto N; Kitagawa H; Tanoue K; Yamazaki H
FEBS Lett; 1987 Dec; 225(1-2):228-32. PubMed ID: 3121391
[TBL] [Abstract][Full Text] [Related]
15. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
Sheu JR; Hung WC; Lee LW; Chang PT; Kan YC; Yen MH
Biochem Biophys Res Commun; 1997 Feb; 231(1):12-6. PubMed ID: 9070210
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
[TBL] [Abstract][Full Text] [Related]
17. Aequorin-detected calcium changes in stimulated thrombasthenic platelets. Aggregation-dependent calcium movement in response to ADP.
Lecompte T; Potevin F; Champeix P; Morel MC; Favier R; Hurtaud MF; Schlegel N; Samama M; Kaplan C
Thromb Res; 1990 Jun; 58(6):561-70. PubMed ID: 2117306
[TBL] [Abstract][Full Text] [Related]
18. Preliminary in vivo studies on the platelet aggregation inhibitory activity of alpha, alpha'-bis[3-(N,N-diethylcarbamoyl)piperidino]-p-xylene dihydrobromide in beagle dogs.
Lawrence WH; Gollamudi R; Dillingham EO; Carter-Burks G; Tisdelle PA; Lasslo A
J Pharm Sci; 1988 May; 77(5):464-5. PubMed ID: 3411473
[No Abstract] [Full Text] [Related]
19. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
Okuma M; Kanaji K; Sensaki S; Uchino H
Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
